Innate and adaptive immunity to tumors: IL-12 is required for optimal responses

European Journal of Immunology

Volumn 30, Issue 4, 2000, Pages 1088-1093

  Grufman, Per ^a   Kärre, Klas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Dendritic cell; IL 12; NK cell; T lymphocyte; Tumor immunity

Indexed keywords

INTERLEUKIN 12;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNIZATION; LYMPHOMA; MIXED LYMPHOCYTE CULTURE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY;

AMINO ACID SEQUENCE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GENE DELETION; H-2 ANTIGENS; IMMUNIZATION; INTERLEUKIN-12; KILLER CELLS, NATURAL; LYMPHOMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; PEPTIDES; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0343570514     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(200004)30:4<1088::AID-IMMU1088>3.0.CO;2-O     Document Type: Article

References (39)

1. Heufler, C., Koch, F., Stanzl, U., Topar, G., Wysocka, M., Trinchieri, G., Enk, A., Steinman, R. M., Romani, N. and Schuler, G., Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur. J. Immunol. 1996. 26: 659-668.
2. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. and Alber, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 1996. 184: 747-752.
3. Kelsall, B. L., Stuber, E., Neurath, M. and Strober, W., Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T cell responses. Ann. N. Y. Acad. Sci. 1996. 795: 116-126.
4. Sousa, C. R., Hieny, S., Scharton-Kersten, T., Jankovic, D., Charest, H., Germain, R. N. and Sher, A., In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 1997. 186: 1819-1829.
5. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993. 260: 547-549.
6. Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M. P., Maggi, E., Trinchieri, G. and Romagnani, S., Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 1993. 177: 1199-1204.
7. + T cells. Eur. J. Immunol. 1994. 24: 343-347.
8. + T cells. J. Immunol. 1995. 154: 5071-5079.
9. Mosmann, T. R. and Coffman, R. L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989. 7: 145-173.
10. Scott, P., Selective differentiation of CD4+ T helper cell subsets. Curr. Opin. Immunol. 1993. 5: 391-397.
11. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B. and Trinchieri, G., Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 1989. 170: 827-845.
12. Stern, A. S., Podlaski, F. J., Hulmes, J. D., et al., Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 1990. 87: 6808-6812.
13. + NK cells. J. Immunol. 1992. 148: 2429-2436.
14. Robertson, M. J., Soiffer, R. J., Wolf, S. F., Manley, T. J., Donahue, C., Young, D., Herrmann, S. H. and Ritz, J., Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 1992. 175: 779-788.
15. Rabinowich, H., Herberman, R. B. and Whiteside, T. L., Differential effects of IL-12 and IL-2 on expression and function of cellular adhesion molecules on purified human natural killer cells. Cell. Immunol. 1993. 152: 481-498.
16. Gately, M. K., Warrier, R. R., Honasoge, S., Carvajal, D. M., Faherty, D. A., Connaughton, S. E., Anderson, T. D., Sarmiento, U., Hubbard, B. R. and Murphy, M., Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo. Int. Immunol. 1994. 6: 157-167.
17. Trinchieri, G., Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994. 84: 4008-4027.
18. Campbell, K. A., Ovendale, P. J., Kennedy, M. K., Fanslow, W. C., Reed, S. G. and Maliszewski, C. R., CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 1996. 4: 283-289.
19. Mattner, F., Magram, J., Ferrante, J., Launois, P., Di Padova, K., Behin, R., Gately, M. K., Louis, J. A. and Alber, G., Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 1996. 26: 1553-1559.
20. Cooper, A. M., Magram, J., Ferrante, J. and Orme, I. M., Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 1997. 186: 39-45.
21. Lu, H. and Zhong, G., Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection. Infect. Immun. 1999. 67: 1763-1769.
22. Brombacher, F., Dorfmuller, A., Magram, J., Dai, W. J., Kohler, G., Wunderlin, A., Palmer-Lehmann, K., Gately, M. K. and Alber, G., IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes. Int. Immunol. 1999. 11: 325-332.
23. Schijns, V. E., Haagmans, B. L., Wierda, C. M., Kruithof, B., Heijnen, I. A., Alber, G. and Horzinek, M. C., Mice lacking IL-12 develop polarized Th1 cells during viral infection. J. Immunol. 1998. 160: 3958-3964.
24. Oxenius, A., Karrer, U., Zinkernagel, R. M. and Hengartner, H., IL-12 is not required for induction of type 1 cytokine responses in viral infections. J. Immunol. 1999. 162: 965-973.
25. Gately, M. K., Gubler, U., Brunda, M. J., Nadeau, R. R., Anderson, T. D., Lipman, J. M. and Sarmiento, U., Interleukin-12: a cytokine with therapeutic potential in oncology and infectious diseases. Ther. Immunol. 1994. 1: 187-196.
26. Nastala, C. L., Edington, H. D., McKinney, T. G., et al., Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J. Immunol. 1994. 153: 1697-1706.
27. Karre, K., Ljunggren, H. G., Piontek, G. and Kiessling, R., Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986. 319: 675-678.
28. Ljunggren, H. G. and Karre, K., Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 1985. 162: 1745-1759.
29. + T cells. Eur. J. Immunol. 1999. 29: 1363-1373.
30. Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C. Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A. and Gately, M. K., IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 1996. 4: 471-481.
31. Smyth, M. J., Kelly, J. M., Baxter, A. G., Korner, H. and Sedgwick, J. D., An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J. Exp. Med. 1998. 188: 1611-1619.
32. Eberl, G., Kessler, B., Eberl, L. P., Brunda, M. J., Valmori, D. and Corradin, G., Immunodominance of cytotoxic T lymphocyte epitopes co-injected in vivo and modulation by interleukin-12. Eur. J. Immunol. 1996. 26: 2709-2716.
33. Wolpert, E. Z., Grufman, P., Sandberg, J. K., Tegnesjo, A. and Karre, K., Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes. J. Immunol. 1998. 161: 4499-4505.
34. Sandberg, J. K., Grufman, P., Wolpert, E. Z., Franksson, L., Chambers, B. J. and Karre, K., Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. J. Immunol. 1998. 160: 3163-3169.
35. Grufman, P., Wolpert, E. Z., Sandberg, J. K. and Karre, K., T cell competition for the antigen-presenting cell as a model for immunodominance in the cytotoxic T lymphocyte response against minor histocompatibility antigens. Eur. J. Immunol. 1999. 29: 2197-2204.
36. Grufman, P., Sandberg, J. K., Wolpert, E. Z. and Karre, K., Immunization with dendritic cells breaks immunodominance in CTL responses against minor histocompatibility and synthetic peptide antigens. J. Leukoc. Biol. 1999. 66: 268-271.
37. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R. M., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693-1702.
38. Schulz, M., Zinkernagel, R. M. and Hengartner, H., Peptide-induced antiviral protection by cytotoxic T cells. Proc. Natl. Acad. Sci. USA 1991. 88: 991-993.
39. Klavinskis, L. S., Whitton, J. L., Joly, E. and Oldstone, M. B., Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 1990. 178: 393-400.